产品名称 NT 157
产品货号 Axon 2238 CAS [1384426-12-3] MF C16H14BrNO5SMW 412.26 Purity: 99% Soluble in DMSO Description Unique allosteric inhibitor of IGF1R. NT 157 promotes ERK-MAPK dependent inhibitory Ser-phosphorylation and degradation of insulin receptor substrate 1 and 2 (IRS1/2) by shifting IGF1R complexation from IRS1/2 to Shc, which results in long-term inhibition of IGF1R signaling and powerful inhibition of tumor cell growth. References Certificates Categories Extra info H. Reuveni et al. Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment. Cancer Res. 2013, 73, 4383-4394.  Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology IGF1R Endocrinology MAPK PI3K-Akt-mTOR RTK class II; EC 2.7.10.1 Unique allosteric inhibitor of IGF1R signaling Chemical name (E)-3-(3-bromo-4,5-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide Parent CAS No. [1384426-12-3] Order Size Unit Price Stock 2 mg €95.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

NT 157

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 2238

CAS [1384426-12-3]

MF C16H14BrNO5S
MW 412.26

  • Purity: 99%
  • Soluble in DMSO

NT 157

Description

Unique allosteric inhibitor of IGF1R. NT 157 promotes ERK-MAPK dependent inhibitory Ser-phosphorylation and degradation of insulin receptor substrate 1 and 2 (IRS1/2) by shifting IGF1R complexation from IRS1/2 to Shc, which results in long-term inhibition of IGF1R signaling and powerful inhibition of tumor cell growth.
产品资料